SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-033227
Filing Date
2021-05-17
Accepted
2021-05-17 17:34:14
Documents
1
Period of Report
2021-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1581
  Complete submission text file 0001209191-21-033227.txt   3060
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address
Grass Charles S. (Reporting) CIK: 0001861112 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36783 | Film No.: 21932739